Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06060873 · ClinicalTrials.gov registry record
MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial
A clinical trial, sponsored by University of Southern California.
- Recruiting
- Registry status
- 418
- Enrollment target
NCT06060873 is a clinical trial that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 418 participants.
The verdict
NCT06060873 is actively recruiting participants, sponsored by University of Southern California.
- RECRUITING
- Registry status
- 418 participants
- Enrollment target
Study Summary
This study evaluates the accuracy of blood-based biomarker testing to predict the presence of active testicular cancer.
Interventions
- OTHER Clinical Stage I Disease
- OTHER Clinical Stage I with relapse, CSII Disease
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 418 participants |
| Start Date | 2023-06-08 |
| Est. Completion | 2028-12-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06060873
The ClinicalTrials.gov registry entry for NCT06060873 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 418 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Clinical Stage I Disease is the first listed.
NCT06060873 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06060873 about?
NCT06060873 is a clinical study titled "MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial". This study evaluates the accuracy of blood-based biomarker testing to predict the presence of active testicular cancer.
What is the current status of trial NCT06060873?
This trial is currently recruiting. The enrollment target is 418 participants. The study started on 2023-06-08. Estimated completion is 2028-12-08.
What interventions are being tested in trial NCT06060873?
The interventions under investigation include: Clinical Stage I Disease (OTHER), Clinical Stage I with relapse, CSII Disease (OTHER).
Who is sponsoring clinical trial NCT06060873?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.